Majority of the health departments and professionals are backing and efficiently supporting the recommendation of the concerned department that boys aged more than 11 years should get themselves a shot of Merck & Co's Gardasil vaccine, which help them protecting themselves against HPV infections.
The support is for the betterment of males worldwide as the vaccine shot will protect the boys from the infections that can become a cause of genital warts, and even oral, penile and anal cancers, confirms the nation's largest group of pediatricians on Monday.
"What we are hoping will come out of this is that we can push this as a cancer vaccine", said Dr. Michael Brady of the American Academy of Pediatrics (AAP). "We now have the ability to interrupt the transmission and the development of cancer”.
Pediatricians have recently announced in their statements that last year’s U. S. vaccine adviser’s and AAP’s statement of providing protection to both males and females from the dangerous illness cancer, until now had vaccination for only girls but HPV shots have been recently suggested for boys to make them also safe from cancer.
In scientific knowledge, HPV or human papillomavirus, is one of the most commonly sexually transmitted disease in the U. S. Thus to protect people from this sexually active disease, Centers for Disease Control and Prevention has suggested to give shots to men also along with routine vaccinations for women.
Professionals highlight that these infections usually don’t cause any severe symptoms and fades off upon its own but in some cases, the infection is accompanied with certain virus types, which can cause genital warts and, rarely, cancer.
"This definitely is a very safe vaccine", agreed Mr. Brady, also of Nationwide Children's Hospital in Columbus, Ohio.
- Postage Prices will Decrease from Sunday; USPS not too Happy About It
- Marriott and Starwood Hotels & Resorts Worldwide Inc Shareholders Approve to $14.41 Sales Deal
- UK plan to impose additional tax on sugary drinks
- Obesity during pregnancy may increase risk of very ‘large babies’
- Dropping Sales at Gap’s Key Brands hurt the Company’s Shares